LobbyingFox Chase Therapeutics Discovery lobbying by quarter
Fox Chase Therapeutics Discovery's latest lobbying report covers Q3 2025, at $10K. The four quarters Q3 2025–Q2 2026 total $10K. Its first report covers Q3 2025; the issues it reports most are Budget/Appropriations.
Fox Chase Therapeutics Discovery
- Latest quarter
- No record
- Q2 2026 · 0 reports
- Last 12 months
- $10K
- Last 4 quarters
- vs last quarter
- No record
- Q2 2026 against the quarter before
- First report
- Q3 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2025 | $10K | 1 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
Policy issues the reports name
- Budget and appropriations1 reports
A report that names several issues counts once for each.
Who was lobbied
- SENATE1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Ikon Public Affairs | $10K | 1 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/10/14for Q3 2025 | Ikon Public Affairs | $10K |
| 25/09/02for Q3 2025 | Ikon Public Affairs | Under $5,000 |